Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Squamous Cell Carcinoma Asia

Takashi Kojima

MD, PhD

🏢National Cancer Center Hospital East🌐Japan

Chief, Department of Gastroenterology and Gastrointestinal Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Takashi Kojima led pivotal Japanese immunotherapy trials for esophageal squamous cell carcinoma including ATTRACTION-3. His research established nivolumab as a treatment option for advanced ESCC after chemotherapy failure. He is a central figure in Japanese and Asia-Pacific esophageal cancer clinical research.

Share:

🧪Research Fields 研究领域

Esophageal squamous cell carcinoma
Immunotherapy
Nivolumab
Japanese clinical trials
GI oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Takashi Kojima 的研究动态

Follow Takashi Kojima's research updates

留下邮箱,当我们发布与 Takashi Kojima(National Cancer Center Hospital East)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment